Gene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the ...

This article is part of Nature Outlook: Skin, an editorially independent supplement produced with financial support from LEO Pharma. About this content. KaDee Troop is the mother of seven adopted ...

A revolutionary treatment brings new hope to those suffering from a devastating rare skin disorder, while showcasing an innovative funding model that could transform rare disease research In a ...

32-year-old Hani Duglof of Woodbury works as an IT specialist. His brother says Duglof hasn't broken the law while waiting for his asylum case to be decided, but he was still picked up by federal ...

U.S. Food and Drug Administration on Tuesday approved Abeona Therapeutics' gene therapy for a rare skin disorder. The gene therapy, called Zevaskyn, is approved to treat adult and pediatric patients ...

Hani Duglof says even though he applied for asylum 12 years ago, and his case is still pending, federal agents told him he isn't in the U.S. legally, and took him into custody.

Barely a year after the U.S. FDA shackled Abeona Therapeutics Inc.’s cell-based gene therapy with a complete response letter, the agency has approved it for treating a rare and genetic skin disease.